TCIM
FLXN

TIAA CREF Investment Management’s Flexion Therapeutics, Inc. FLXN Stock Holding History

TIAA CREF Investment Management’s Portfolio FLXN Stock Details FLXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$1.05M Buy
84,284
+837
+1% +$11.2K ﹤0.01% 2297
2018
Q4 		$945K Sell
83,447
-1,623
-2% -$25.4K ﹤0.01% 2302
2018
Q3 		$1.59M Sell
85,070
-5,393
-6% -$124K ﹤0.01% 2235
2018
Q2 		$2.34M Sell
90,463
-735
-0.8% -$19.1K ﹤0.01% 2088
2018
Q1 		$2.04M Sell
91,198
-4,242
-4% -$104K ﹤0.01% 2088
2017
Q4 		$2.39M Buy
95,440
+22,101
+30% +$541K ﹤0.01% 2031
2017
Q3 		$1.77M Sell
73,339
-1,063
-1% -$25K ﹤0.01% 2240
2017
Q2 		$1.5M Sell
74,402
-7,626
-9% -$159K ﹤0.01% 2351
2017
Q1 		$2.21M Sell
82,028
-1,863
-2% -$38K ﹤0.01% 2087
2016
Q4 		$1.6M Buy
83,891
+7,906
+10% +$151K ﹤0.01% 2307
2016
Q3 		$1.49M Buy
75,985
+14,366
+23% +$243K ﹤0.01% 2338
2016
Q2 		$922K Buy
61,619
+15,720
+34% +$198K ﹤0.01% 2552
2016
Q1 		$422K Hold
45,899
– – ﹤0.01% 2834
2015
Q4 		$884K Hold
45,899
– – ﹤0.01% 2648
2015
Q3 		$682K Buy
45,899
+15,004
+49% +$352K ﹤0.01% 2787
2015
Q2 		$676K Buy
30,895
+11,662
+61% +$235K ﹤0.01% 2869
2015
Q1 		$433K Hold
19,233
– – ﹤0.01% 2961
2014
Q4 		$388K Sell
19,233
-158
-0.8% -$2.86K ﹤0.01% 3017
2014
Q3 		$354K Hold
19,391
– – ﹤0.01% 3032
2014
Q2 		$261K Buy
19,391
+11,641
+150% +$159K ﹤0.01% 3071
2014
Q1 		$127K Buy
+7,750
New +$134K ﹤0.01% 3097

Other funds holding FLXN

MVP
Miller Value Partners Sarasota, Florida $423M AUM 49.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

TIAA CREF Investment Management's FLXN Position: Q1 2019 in Review

TIAA CREF Investment Management increased its Flexion Therapeutics, Inc. (FLXN) stake by 1% in Q1 2019, buying an estimated $11.2K and bringing the position to 84,284 shares worth $1.05M. The position accounts for ﹤0.01% of the portfolio, ranked #2297.

TIAA CREF Investment Management first reported a position in FLXN in Q1 2014 and has held it in 21 quarters since. The position peaked at $2.39M in Q4 2017. 129 funds tracked by Wall St. Rank hold FLXN as of Q1 2019.

  • TIAA CREF Investment Management held 84,284 shares of Flexion Therapeutics, Inc. worth $1.05M as of Q1 2019.
  • TIAA CREF Investment Management bought 837 Flexion Therapeutics, Inc. shares in Q1 2019, an estimated $11.2K.
  • Flexion Therapeutics, Inc. made up ﹤0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #2297 holding.
  • TIAA CREF Investment Management first reported a position in Flexion Therapeutics, Inc. in Q1 2014 and has held it in 21 quarters since.
  • TIAA CREF Investment Management's Flexion Therapeutics, Inc. position peaked at $2.39M in Q4 2017.
  • 129 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.